ODYY · Odyssey Health, Inc.
$0.01
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jun 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The operating deficit and negative working capital at April 30, 2026, indicate substantial doubt about our ability to continue as a going concern. Our continued existence depends on the success of our efforts to raise additional capital necessary to meet our obligations as they come due and to obtain sufficient capital to execute our business plan. We may obtain capital primarily through issuances of debt or equity or entering into collaborative arrangements with corporate partners. There can be no assurance that we will be successful in completing additional financing or collaboration transactions or, if financing is available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we may be required to scale down or perhaps even cease operations. The issuance of additional equity securities could result in a significant dilution in the equity interests of our current stockholders. Obtaining commercial loans, assuming those loans would be available, would increase our liabilities and future cash commitments. Our financial statements do not include adjustments that might result from the outcome of this uncertainty. We are continually adjusting our business plan to reflect our current liquidity expectations. If we are unable to raise additional capital, secure additional debt financing, secure additional equity financing, secure a strategic partner, reduce our operating expenditures, or seek bankruptcy protection, we will adjust our business plan. Given our recurring losses, negative cash flow, and accumulated deficit, there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Jun 12, 2026
Market Cap
$706,780
Shares
100.97M
Volume · Oct 19
26.03K
Avg daily vol (3M)
180.82K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.01
Day$0.01–0.01
52W close$0.00–0.10
Avg vol 30d209K
Short int60K · 0.1% float · 1.0d
Short vol38%
DataJan 2021–Oct 2026
Filing10-Q · Jun 12
Up next
filed Jun 12, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$3.57M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+78.3%
Year over year · more shares
Price change (1Y)
-93.6%
Trailing year
Short interest
0.1%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−81%
below
Price vs 50-day avg
−25%
below
RSI (14)
38
neutral
MACD trend
Negative
52-week position
3%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−33%
trailing
6-month return
−89%
trailing
YTD return
−80%
this year
Relative strength
−96%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.06% of float · ▼ -2.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Squeeze score
23
low risk · 0–100
Fundamentals
EPS growth
−100%
Y/Y
Free cash flow
$-347.4K
Balance sheet
$556.6K
net cash
Quant / Vol
risk profile
Volatility
261%
annualized · 1-yr
Max drawdown
−96%
past year
ATR
25.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−81%
Bearish
Price vs 50-day avg
−25%
Bearish
RSI (14)
38
Neutral
MACD trend
Negative
Bearish
52-week position
3%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.06% of float · ▼ -2.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Price context
position in its 52-week range
Range low $0
Now $0 · 3%
Range high $0
vs 200-day avg -81%
vs 50-day avg -25%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ODYY
this stock
Odyssey Health, Inc.
|
$706,780 | -79.7% | — | — | 0.1% |
|
ABT
Abbott Laboratories
|
$171.24B | -19.8% | +5.7% | 31.8 | 0.8% |
|
MDT
Medtronic plc
|
$121.04B | -3.2% | +8.4% | 23.3 | 3.1% |
|
SYK
Stryker Corp
|
$116.76B | -15.3% | +11.2% | 31.5 | 1.5% |
|
BSX
Boston Scientific Corp
|
$64.51B | -53.3% | +12.5% | 18.0 | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Holders
1
- % held
- 1.0%
- Net QoQ
- 0 sh
- Top holder
- ORLEANS CAPITAL MANAGEMEN…
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ODYY | -16.3% | -33.0% | -88.6% | -20.2% | -79.7% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -14.8% | -32.1% | -96.3% | -20.7% | -92.1% |